| Reference | Age (sex) | Clinical manifestations | Laboratory findings | NCS | Other | Treatment | Outcome |
| [7] | 58 M | Symmetric weakness, hyporeflexia, and asthma | Eosinophilia, elevated ERS, and p-ANCA+ | Mixed demyelinating polyneuropathy and multifocal absent F-waves | Lung infiltrates | P, CyC, and S | Expired | [8] | 57 M | Symmetric weakness and hyporeflexia | p-ANCA+ and elevated ERS | Demyelinating polyneuropathy and multifocal absent F-waves | Nephritis | S | Improved |
| [9] | 51 F | Symmetric weakness, hyporeflexia, asthma, and nasal polyposis | Eosinophilia, elevated CRP, and ANCA− | Motor asymmetric axonal polyneuropathy and multifocal absent F-waves | | IvIG and S | Improved |
| [10] | 74 M | Symmetric weakness, hyporeflexia, and asthma | Eosinophilia | Mixed demyelinating polyneuropathy | | S and CyC | Improved |
| [11] | 64 F | Asymmetric weakness, hyporeflexia, asthma, diplopia, and sinusitis | Elevated ESR, eosinophilia, and p-ANCA+ | Motor axonal and demyelinating polyneuropathy and multifocal absent F-waves | Multiorgan disease | IvIG, CyC, and S | Expired |
| Present case | 36 F | Symmetric weakness, hyporeflexia, asthma, purpura, and pansinusitis | Elevated ESR, eosinophilia, and p-ANCA+ | Mixed axonal asymmetric polyneuropathy | | S and CyC | Improved |
|
|